U.S. markets close in 2 hours 13 minutes

InMed Pharmaceuticals Inc. (IN.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
4.4500-0.2900 (-6.12%)
As of 1:07PM EDT. Market open.
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Premium required to access quarterly data
Quarterly
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Breakdown
ttm
6/30/2020
6/30/2019
6/30/2018
6/30/2017
Total Revenue
0
0
0
0
0
Operating Expense
12,112
12,112
13,644
8,610
4,474
Operating Income
-12,112
-12,112
-13,644
-8,610
-4,474
Net Non Operating Interest Income Expense
146.508
146.508
433.803
88.337
-
Other Income Expense
108.376
108.376
-44.858
0.287
-0.322
Pretax Income
-11,857
-11,857
-13,255
-8,521
-4,474
Net Income Common Stockholders
-11,857
-11,857
-13,255
-8,521
-4,474
Diluted NI Available to Com Stockholders
-11,857
-11,857
-13,255
-8,521
-4,474
Basic EPS
-
-
-0.0026
-0.002
-0.0017
Diluted EPS
-
-
-0.0026
-0.002
-0.0017
Basic Average Shares
-
-
5,192
4,317
2,933
Diluted Average Shares
-
-
5,192
4,317
2,933
Rent Expense Supplemental
95.092
95.092
199.767
133.09
50.957
Total Expenses
12,112
12,112
13,644
8,610
4,474
Net Income from Continuing & Discontinued Operation
-11,857
-11,857
-13,255
-8,521
-4,474
Normalized Income
-11,965
-11,965
-13,210
-8,521
-4,474
Interest Income
171.934
171.934
433.803
88.337
-
Interest Expense
25.426
25.426
-
-
-
Net Interest Income
146.508
146.508
433.803
88.337
-
EBIT
-11,831
-11,831
-13,644
-8,610
-4,474
EBITDA
-11,610
-
-
-
-
Reconciled Depreciation
221.218
221.218
124.344
117.845
97.823
Net Income from Continuing Operation Net Minority Interest
-11,857
-11,857
-13,255
-8,521
-4,474
Total Unusual Items Excluding Goodwill
108.376
108.376
-44.858
0.287
-0.322
Total Unusual Items
108.376
108.376
-44.858
0.287
-0.322
Normalized EBITDA
-11,719
-11,719
-13,475
-8,492
-4,375
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0